Publications by authors named "Binting Wu"
Article Synopsis
- The study investigates the reasons behind lower red blood cell transfusion rates in China compared to Western countries by analyzing 5050 transfused patients across five hospitals.
- Results show that medical patients in China have significantly lower pretransfusion hemoglobin levels (around 6.3 g/dL) compared to surgical patients (about 8.1 g/dL) and patients in the U.S., suggesting a varied approach to what constitutes a transfusion trigger.
- The research concludes that while surgical transfusion triggers are similar between China and the U.S., medical patients have much lower hemoglobin levels, raising questions about the clinical implications of these lower transfusion thresholds in China.
Background: Transfusion transmission of hepatitis E virus (HEV) is an emerging health risk, yet blood donors are rarely screened for this pathogen. Many blood centers instituted screening of blood donors for elevated levels of alanine aminotransferase (ALT) levels to prevent hepatitis C virus, which has continued in China. We evaluated whether elevated ALT levels were associated with HEV among blood donors in China.
View Article and Find Full Text PDFBackground: In most countries, the plasma for derivative production includes two types of plasma, apheresis plasma (AP) and recovered plasma (RP). However, the plasma recovered from whole blood is not permitted for manufacture in China. Because of the lack of source plasma and the surplus of RP, the Chinese government is considering allowing RP as an equivalent source for the production of plasma derivatives.
View Article and Find Full Text PDF